Skip to main content
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. — Investor Relations & Filings

Ticker · WHWK ISIN · US00032Q1040 LEI · 549300G3U7TKW1M58L09 US Professional, scientific and technical activities
Filings indexed 516 across all filing types
Latest filing 2019-07-08 Director's Dealing
Country US United States of America
Listing US WHWK

About Whitehawk Therapeutics, Inc.

https://ir.whitehawktx.com/

Whitehawk Therapeutics, Inc. is a preclinical-stage oncology company focused on developing advanced antibody-drug conjugate (ADC) therapies. The company applies next-wave platform technologies to established tumor biology to create treatments for difficult-to-treat cancers. Its portfolio features three ADC assets, which are engineered to overcome the limitations of first-generation predecessors through improved tumor targeting and clinical strategies. These assets are in-licensed from WuXi Biologics under an exclusive agreement for global development and commercialization.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2019-07-08 English
4 Filing
Director's Dealing
2019-06-19 English
4 Filing
Director's Dealing
2019-06-19 English
4 Filing
Director's Dealing
2019-06-19 English
4 Filing
Director's Dealing
2019-06-19 English
8-K Filing
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 18, 2019, by Aerpio Pharmaceuticals, Inc. The key content is the submission of matters to a vote of security holders at the Annual Meeting held on June 18, 2019. It details the voting results for director elections and ratification of the independent auditor. The document does not contain full financial statements or detailed financial performance data, but rather official voting results from the shareholder meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4175 characters, which is consistent with a voting results announcement rather than a full report or proxy statement. Therefore, the correct classification is DVA with high confidence.
2019-06-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.